Gene · 6584
Papers1,762
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,762
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| L-carnitine modified nanoparticles target the OCTN2 transporter to improve the oral absorption of jujuboside B. | Eur J Pharm Biopharm | 2024 | 38280469 | PubTator, text mining | PubMed |
| Adipose Stromal Cell-Derived Secretome Attenuates Cisplatin-Induced Injury In Vitro Surpassing the Intricate Interplay between Proximal Tubular Epithelial Cells and Macrophages. | Cells | 2024 | 38247813 | PubTator, text mining | PubMed |
| The genomic alterations in glioblastoma influence the levels of CSF metabolites. | Acta Neuropathol Commun | 2024 | 38243318 | PubTator, text mining | PubMed |
| Single-cell RNA-Seq Elucidates the Crosstalk Between Cancer Stem Cells and the Tumor Microenvironment in Hepatocellular Carcinoma. | J Cancer | 2024 | 38230205 | PubTator, text mining | PubMed |
| Newborn screening for fatty acid oxidation disorders in a southern Chinese population. | Heliyon | 2024 | 38187300 | PubTator, text mining | PubMed |
| A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features. | BMC Cardiovasc Disord | 2024 | 38166572 | PubTator, text mining | PubMed |
| Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia. | Int J Biol Sci | 2024 | 38164178 | PubTator, text mining | PubMed |
| Newborn screening for primary carnitine deficiency using a second-tier genetic test. | J Pediatr Endocrinol Metab | 2024 | 38158618 | PubTator, text mining | PubMed |
| Screening of 1.17 million newborns for inborn errors of metabolism using tandem mass spectrometry in Shanghai, China: A 19-year report. | Mol Genet Metab | 2024 | 38061323 | PubTator, text mining | PubMed |
| Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. | Transl Oncol | 2024 | 38042134 | PubTator, text mining | PubMed |
| Clinical and genetic analysis of 26 Chinese patients with neonatal intrahepatic cholestasis due to citrin deficiency. | Clin Chim Acta | 2024 | 37890575 | PubTator, text mining | PubMed |
| A Comprehensive LOVD Database for Fatty Acid Oxidation Disorders in Chinese Populations. | Hum Mutat | 2023 | 40225143 | PubTator, text mining | PubMed |
| Biomolecules of Muscle Fatigue in Metabolic Myopathies. | Biomolecules | 2023 | 38254650 | PubTator, text mining | PubMed |
| The Impact of Integration of a Genetic Clinic Into a Pediatric Cardiac Unit. | Cureus | 2023 | 38249165 | PubTator, text mining | PubMed |
| Sensitivity of Human Induced Pluripotent Stem Cells and Thereof Differentiated Kidney Proximal Tubular Cells towards Selected Nephrotoxins. | Int J Mol Sci | 2023 | 38203251 | PubTator, text mining | PubMed |
| Short stature with low serum alkaline phosphatase activity: a case report of hypophosphatasia. | Ann Pediatr Endocrinol Metab | 2023 | 38173385 | PubTator, text mining | PubMed |
| Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders. | Pharmaceuticals (Basel) | 2023 | 38139841 | PubTator, text mining | PubMed |
| Expression of Claudin-9 (CLDN9) in Breast Cancer, the Clinical Significance in Connection with Its Subcoat Anchorage Proteins ZO-1 and ZO-3 and Impact on Drug Resistance. | Biomedicines | 2023 | 38137355 | PubTator, text mining | PubMed |
| Newborn Genetic Screening-Still a Role for Sanger Sequencing in the Era of NGS. | Int J Neonatal Screen | 2023 | 38132826 | PubTator, text mining | PubMed |
| Primary carnitine deficiency: Estimation of prevalence in Chinese population and insights into newborn screening. | Front Genet | 2023 | 38125748 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6584/papers?page=7